At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.
The Role
The Director of US Medical Affairs Solid Tumors Strategy will report to the Senior Director, US Medical Affairs Solid Tumors Strategy Lead. S/he will provide medical affairs leadership for assigned asset(s)/indications and support for the overall oncology solid tumor portfolio. The individual will lead the development and execution of the US Medical Affairs strategy that is aligned with the company's goals and meets the needs of the US healthcare market through collaboration with US Commercialization, Global Medical Affairs, Clinical Development, Regulatory, and other cross functional teams.
We have a hybrid model that requires being onsite in Princeton, NJ 60% of the time.
Responsibilities
Responsible for the US Medical Affairs strategic and tactical planning in coordination with the Global Medical Affairs and other cross-functional teams.
Represent US Medical Affairs as a disease area expert in both internal and external venues including the US/Global cross-functional teams, clinical development teams, advisory boards, steering committees, professional society meetings, congresses, and local symposia.
Lead pre/peri/post launch medical activities for assigned asset(s) entering the US market.
Collaborate with US Field Medical Affairs to identify, guide and execute disease/indication regional strategies and tactics with appropriate use of resources.
Work with clinical development, regulatory, commercial, and market access teams to incorporate insights into product strategies and to support product launches and lifecycle management.
Participate in the evaluation and support of investigator sponsored trials (IST). Oversee the generation of clinical and real-world evidence in the US that supports the value proposition of our therapies. Ensure the effective dissemination of the data generated through publications, presentations, and other communications.
Provide strategic input and review of congress abstracts, posters, presentation slides, manuscripts, educational materials, advisory board meeting materials, and medical information response documents, etc.
Build and maintain strong relationships with key US Thought Leaders (TLs), healthcare professionals, and patient advocacy groups to gather insights, drive advocacy, and ensure our therapies meet the needs of patients and healthcare providers in the US.
Prioritize and monitor US Medical Affairs tactics performance to ensure execution excellence.
Stay abreast of the latest trends, developments, and competitive landscape in the US healthcare market, particularly within oncology and antibody therapeutics. Use this knowledge to inform and adapt to the US medical strategy as needed.
Develop a high-performance team. Foster a culture of excellence, collaboration, and continuous learning.
Requirements
Advanced degree in health-related field (MD, PhD, or PharmD preferred). Experience in oncology required.
At least 8 years of experience in medical affairs, clinical development, or related roles within the biotechnology or pharmaceutical industry, with a strong focus on oncology.
Experience in the conduct of clinical trials in oncology. Proficiency in clinical data review and interpretation.
Solid experience in translating medical/clinical information into medical affairs strategies.
In-depth knowledge of the US healthcare system, including regulatory requirements, payer landscape, and healthcare provider networks.
Demonstrated customer focus orientation & credibility with customers.
Excellent communication and interpersonal skills, with the ability to engage and influence a wide range of internal and external stakeholders.
Strong matrix leadership skills with a track record of building and managing effective teams.
Ability to navigate and succeed in a dynamic, fast-paced environment with a high degree of collaboration and teamwork.
Business travel required (~ 35%)
For US based candidates, the proposed salary band for this position is as follows:
$206,250.00---$343,750.00The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.
About You
You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
You are a generous collaborator who can work in teams with diverse backgrounds
You are determined to do and be your best and take pride in enabling the best work of others on the team
You are not afraid to grapple with the unknown and be innovative
You have experience working in a fast-growing, dynamic company (or a strong desire to)
You work hard and are not afraid to have a little fun while you do so
Locations
Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.
About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our commitment to diversity, equity, and inclusion
We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
